Iliac Angioplasties: Impact of the Fusion of Images on the Irradiation Rate
AIFITI
1 other identifier
interventional
350
1 country
2
Brief Summary
Atherosclerosis can cause the arteries to narrow (stenosis) or clog (occlude), leading to reduced blood flow. Arteriography or angiography is a radiological examination of the arteries which will make it possible to confirm and quantify the severity of the damage to the artery and which, in certain cases, can be directly treated by angioplasty with or without stenting (selective angioplasty). Digital subtraction angiography (DSA), the reference technique, provides good image quality. The fluoroscopy used today during angioplasty procedures makes it possible to obtain images in real time and to guide the progression of the endovascular material in the arterial axis. Image fusion is an established technique for the endovascular treatment of aortic aneurysms. The feasibility of image fusion for the iliac arterial axes has already been assessed and is reproducible. However, there is no assessment of the irradiation rate in iliac angioplasty, using intraoperative image fusion, compared to standard angioplasty practices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2021
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 25, 2021
CompletedFirst Submitted
Initial submission to the registry
April 5, 2022
CompletedFirst Posted
Study publicly available on registry
April 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedApril 29, 2022
April 1, 2022
2.4 years
April 5, 2022
April 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Irradiation rate
mean irradiation rate during iliac angioplasty will be compared between the 2 study groups The primary endpoint of the research is the patient's intraoperative irradiation rate defined by measuring the dose area product (DAP) in Gy.cm2
"immedialtely at the end of surgery procedure"
Study Arms (2)
Angioplasty DSA
ACTIVE COMPARATORReference procedure (DSA), comprising: production of fluoroscopy images for placement of endoluminal material and navigation, subtracted angiography with placement of flaps to reduce the field of rays ("collimation ") for visualization of the arterial axis (in low dose, pulsed with maximum collimation), the realization of possible oblique incidences (external iliac), the catheterization with or without placement of a post-inflation stent, then the realization of a second subtracted control angiogram.
Angioplasty DSA+Fusion
EXPERIMENTALProcedure under study (DSA+Fusion), including: production of fluoroscopy images for placement of the endoluminal material and navigation, 2 fluoroscopy images specifically for image fusion registration (from the images scanner), selective angiography under fluoroscopy with collimation to improve registration (in low dose mode, pulsed with maximum collimation), if possible no oblique views (3D markers of the fusion), with or without placement of post-inflation stent followed by subtracted control angiography
Interventions
Angioplasty Iliac under additional 3D Images merged as surgery support
Eligibility Criteria
You may qualify if:
- Patient, male or female, over the age of 18
- Patient with a primary and/or external iliac lesion (TASC A, B and C)
- Patient for whom unilateral angioplasty is indicated
- Affiliated patient or beneficiary of a social security scheme
- Patient having been informed and having signed a written consent.
You may not qualify if:
- Patient with a BMI strictly less than 18.5 or greater than or equal to 30.0 kg/m²
- Patient with long iliac thrombosis (including the primitive iliac and the external iliac)
- Patient with a known allergy to iodine
- Patient with a contraindication related to the procedure
- Patient for whom a bilateral iliac procedure is indicated
- Patient requiring an associated infra-inguinal endovascular procedure
- Patient participating in another clinical study
- Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
- Pregnant, breastfeeding or parturient women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ramsay Générale de Santélead
- European Clinical Trial Experts Networkcollaborator
Study Sites (2)
CHU de Nantes
Nantes, Brittany Region, 44093, France
Saint Martin Private Hospital
Caen, Normandy, 14050, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2022
First Posted
April 29, 2022
Study Start
May 25, 2021
Primary Completion
September 30, 2023
Study Completion
September 30, 2023
Last Updated
April 29, 2022
Record last verified: 2022-04